# Test Results: writing/results-description.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-23.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** writing/results-description.md
- **Model:** claude-sonnet-4.6
- **Model ID (pinned):** claude-sonnet-4-6
- **Endpoint:** native
- **Date:** 2026-06-23
- **Tester:** cross-model-harness
- **Assembly strategy:** concat
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
```
Context: I am writing the Results section for a manuscript on {RESEARCH_TOPIC}. I need to describe the findings shown in {FIGURE/TABLE/ANALYSIS DESCRIPTION}.

My data summary:
{PASTE YOUR DATA: statistical output, figure description, table, or key numbers}

Research question this addresses: {SPECIFIC_QUESTION}

Task: Write a results paragraph describing these findings. Follow these guidelines:

1. **State the main finding first**: Lead with what the data show, not the methods used to show it.

2. **Report specific values**: Include effect sizes, confidence intervals, p-values, or other relevant statistics as provided.

3. **Describe patterns accurately**: For figures, describe trends, differences, or distributions visible in the data.

4. **Reference the figure/table**: Include appropriate references (e.g., "Figure 2A").

5. **Maintain appropriate scope**: Describe what IS shown; do not extrapolate beyond the data.

Constraints:
- Use ONLY the data I have provided—do not invent statistics or findings
- Distinguish between statistically significant and non-significant findings
- Do not interpret causation from correlation
- Do not include discussion of mechanisms or implications (that's for Discussion)
- If the data are unclear or seem inconsistent, flag this rather than smoothing over it
- Flag any values that seem unusual with [VERIFY: concern]

Output format: One to three paragraphs of results prose, with figure/table references in parentheses.

Context: I am writing the Results section for a manuscript on probiotic effects on gut barrier function. I need to describe the findings shown in Figure 3 (intestinal permeability assay).

My data summary:
FITC-dextran permeability (serum fluorescence, μg/mL, mean ± SEM):
- Control: 2.1 ± 0.3 (n=8)
- DSS only: 8.7 ± 1.2 (n=8)
- DSS + Probiotic: 4.3 ± 0.6 (n=8)

Statistical test: One-way ANOVA with Tukey post-hoc
- Overall ANOVA: F(2,21) = 18.4, p < 0.001
- DSS vs Control: p < 0.001
- DSS + Probiotic vs DSS: p = 0.003
- DSS + Probiotic vs Control: p = 0.048

Additional notes:
- FITC-dextran administered by oral gavage 4 hours before sacrifice
- Higher fluorescence = increased permeability (leaky gut)
- DSS = dextran sulfate sodium colitis model

Research question: Does probiotic treatment protect against colitis-induced intestinal barrier dysfunction?
```

## Model Output
```
## Results Paragraph

Probiotic treatment significantly attenuated colitis-induced intestinal barrier dysfunction, though permeability did not fully return to baseline levels. As shown in Figure 3, DSS-treated animals exhibited a marked increase in serum FITC-dextran fluorescence compared to untreated controls (8.7 ± 1.2 vs. 2.1 ± 0.3 μg/mL; p < 0.001, Tukey post-hoc), confirming that DSS administration successfully elevated intestinal permeability. Animals receiving probiotic treatment alongside DSS showed substantially reduced serum fluorescence relative to the DSS-only group (4.3 ± 0.6 vs. 8.7 ± 1.2 μg/mL; p = 0.003), representing an approximately 51% reduction in FITC-dextran translocation. Overall, the one-way ANOVA indicated a significant effect of treatment group on intestinal permeability (F(2,21) = 18.4, p < 0.001).

Despite this partial recovery, serum fluorescence in the DSS + Probiotic group remained significantly elevated compared to untreated controls (4.3 ± 0.6 vs. 2.1 ± 0.3 μg/mL; p = 0.048, Figure 3), indicating that probiotic supplementation reduced but did not fully normalize barrier permeability under these experimental conditions.

---

**⚑ One flag for your attention:**

> **[VERIFY: sample size / degrees of freedom]** With n = 8 per group (total N = 24), the within-groups degrees of freedom for a one-way ANOVA should be 21 (i.e., 24 − 3), which is consistent with the reported F(2,21). This checks out, but please confirm no animals were excluded from any group prior to analysis, as any exclusions would alter the expected df and should be reported.
```

## Overall Assessment
- **Recommendation:** Pass
- **Notes:**
## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
